Real-time continuous glucose monitoring vs self-monitoring of blood glucose in distinct multi-ethnic cohorts of patients living with insulin-treated type 2 diabetes in the United States: A cost-utility analysis from a Medicare perspective
In a simulated cohort representative of individuals living with T2D and receiving insulin therapy, rt-CGM may be cost-effective compared with SMBG from a Medicare perspective. Therefore, rt-CGM plausibly possesses the potential to address existing racial and ethnic disparities in diabetes-related outcomes for patients within the United States.
Authors
- Gregory J. Norman (ORCID: https://orcid.org/0000-0001-7989-9597)
- Richard Fulton Pollock (ORCID: https://orcid.org/0000-0002-9873-7507)
- Hamza Alshannaq
- Peter Lynch (ORCID: https://orcid.org/0000-0002-4278-5200)
- Jéssica Yumi Matuoka (ORCID: https://orcid.org/0000-0002-7956-1606)
- Waqas Ahmed (ORCID: https://orcid.org/0000-0002-9035-7614)
Institutions
- Dexcom (United States) (US)
- A-T Society (GB)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2025-07-24
- DOI
- https://doi.org/10.18553/jmcp.2025.31.8.752
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00